scholarly journals Evidence for a hijacked brain reward system but no desensitized threat system in quitting motivated smokers: An fMRI study

Addiction ◽  
2021 ◽  
Author(s):  
Stefanie L. Kunas ◽  
Heiner Stuke ◽  
Andreas Heinz ◽  
Andreas Ströhle ◽  
Felix Bermpohl
Heliyon ◽  
2020 ◽  
Vol 6 (5) ◽  
pp. e03947
Author(s):  
Madoka Anan ◽  
Ryoko Higa ◽  
Kenshiro Shikano ◽  
Masahito Shide ◽  
Akinobu Soda ◽  
...  

2012 ◽  
Vol 22 ◽  
pp. S128-S129
Author(s):  
A. Wallén-Mackenzie ◽  
E. Arvidsson ◽  
E. Restrepo ◽  
S. Pupe Johann ◽  
E. Perland ◽  
...  

2015 ◽  
Vol 13 (3) ◽  
pp. 79-80
Author(s):  
Liselotte van Bloemendaal ◽  
Dick J. Veltman ◽  
Jennifer S. Ten Kulve ◽  
Paul Fc. Groot ◽  
Henricus G. Ruhé ◽  
...  

2013 ◽  
Vol 16 (4) ◽  
pp. 763-769 ◽  
Author(s):  
Joar Guterstam ◽  
Nitya Jayaram-Lindström ◽  
Simon Cervenka ◽  
J. James Frost ◽  
Lars Farde ◽  
...  

Abstract Studies in rodents have shown that psychostimulant drugs such as cocaine and amphetamine cause endorphin release in the brain reward system. There is also evidence for the involvement of the opioid system in human psychostimulant dependence. The acute effects of an i.v. psychostimulant drug on the brain opioid system, however, have not yet been investigated in humans. We hypothesized that an i.v. dose of amphetamine as compared to placebo would cause an opioid release in the human brain reward system, measurable as a reduction of the binding potential of the µ-opioid receptor radioligand [11C]carfentanil. Ten healthy young men were examined using positron emission tomography (PET) and [11C]carfentanil in three sessions: at baseline; after placebo; after an i.v. amphetamine dose of 0.3 mg/kg bodyweight. The order of amphetamine and placebo was double-blinded and randomized. PET examinations were performed with a Siemens high resolution research tomograph. Data were analysed with the simplified reference tissue model, applying manually drawn regions of interest for every subject. Using repeated measures analysis of variance, we found no significant differences in [11C]carfentanil binding potential between amphetamine and placebo conditions in any of the investigated brain regions. In contrast to data from rodent studies and a recent study of oral amphetamine administration in humans, an i.v. dose of amphetamine does not cause any acute opioid release in healthy human subjects. The postulated role of the opioid system in mediating the effects of amphetamine needs to be further investigated in animal models of the disease as well as in patient populations.


1989 ◽  
Vol 67 (9) ◽  
pp. 1158-1167 ◽  
Author(s):  
Michael A. Bozarth

Research with laboratory animals has provided several insights into the nature of cocaine abuse and addiction. First, the nature of drug addiction has been reevaluated and the emphasis has shifted from physical dependence to compulsive drug-taking behavior. Second, animal studies suggest that cocaine is at least as addictive as heroin and possibly even more addictive. Third, cocaine is potentially more dangerous than heroin as evidenced by the higher fatality rate seen in laboratory animals given unlimited access to these drugs. Fourth, the neural basis of cocaine reinforcement has been identified and involves an enhancement of dopaminergic neurotransmission in the ventral tegmental dopamine system. Other addictive drugs (e.g., opiates) may also derive at least part of their reinforcing impact by pharmacologically activating this reward system. Fifth, although the biological consequences of repeated cocaine self-administration on central nervous system functioning are poorly understood, preliminary findings suggest that intravenous cocaine self-administration may decrease neural functioning in this brain reward system. This has important clinical implications because diminished functioning of an important brain reward system may significantly contribute to relapse into cocaine addiction. These and other findings from experimentation with laboratory animals suggest new considerations for the etiology and treatment of drug addiction.Key words: addiction, cocaine, dopamine, reward, withdrawal syndrome.


2017 ◽  
Vol 27 ◽  
pp. S1070
Author(s):  
A. Just ◽  
C. Meng ◽  
D.G. Smith ◽  
E.T. Bullmore ◽  
T.W. Robbins ◽  
...  

2002 ◽  
Vol 17 ◽  
pp. 221
Author(s):  
A. Heinz ◽  
J. Wrase ◽  
S. Grüsser ◽  
D. Braus ◽  
P. Bartenstein ◽  
...  

Author(s):  
Tayfun Uzbay

Neuromarketing is a relatively new concept. It is simply focused on the relationship between consumer behavior and the brain. For this purpose, it analyzes various customer behaviors towards the product and purchase by using various brain imaging techniques and behavioral methodology. Some limbic structures of brain such as ventral tegmental area (VTA), nucleus acumbens (NAc), and amygdala have a link to prefrontal cortex (PFC) by dopaminergic mesocorticolimbic pathway. This functional link is called brain reward system (BRS). BRS has a crucial role in the decision-making process of humans during shopping as well as addiction processes of brain. Studies investigating BRS in neuromarketing are very limited. In the chapter, working principles of BRS in neuromarketing and association with human shopping behaviors and shopping addiction/dependence has been investigated and discussed.


Sign in / Sign up

Export Citation Format

Share Document